The unique structural characteristics of threedimensional (3D) covalent organic frameworks (COFs) like high surface areas, interconnected pore system and readily accessible active sites render them promising platforms for a wide set of functional applications. Albeit promising, the reticular construction of 3D COFs with large pores is a very demanding task owing to the formation of interpenetrated frameworks. Herein we report the designed synthesis of a 3D non-interpenetrated stp net COF, namely TUS-64, with the largest pore size of all 3D COFs (47 Å) and record-low density (0.106 g cm À 3 ) by reticulating a 6-connected triptycenebased linker with a 4-connected porphyrin-based linker. Characterized with a highly interconnected mesoporous scaffold and good stability, TUS-64 shows efficient drug loading and controlled release for five different drugs in simulated body fluid environment, demonstrating the competency of TUS-64 as drug nanocarriers.

The unique structural characteristics of three-dimensional (3D) covalent organic frameworks (COFs) like high surface areas, interconnected pore system and readily accessible active sites render them promising platforms for a wide set of functional applications. Albeit promising, the reticular construction of 3D COFs with large pores is a very demanding task owing to the formation of interpenetrated frameworks. Herein we report the designed synthesis of a 3D non-interpenetrated stp net COF, namely TUS-64, with the largest pore size of all 3D COFs (47 Å) and record-low density (0.106 g cm-3) by reticulating a 6-connected triptycene-based linker with a 4-connected porphyrin-based linker. Characterized with a highly interconnected mesoporous scaffold and good stability, TUS-64 shows efficient drug loading and controlled release for five different drugs in simulated body fluid environment, demonstrating the competency of TUS-64 as drug nanocarriers

The construction of functionalized covalent organic frameworks (COFs) is of great significance for broadening their potential applications, but are yet challenging to achieve, especially to three-dimensional (3D) COFs, because the...

The unique structural characteristics of three‐dimensional (3D) covalent organic frameworks (COFs) like high surface areas, interconnected pore system and readily accessible active sites render them promising platforms for a wide set of functional applications. Albeit promising, the reticular construction of 3D COFs with large pores is a very demanding task owing to the formation of interpenetrated frameworks. Herein we report the designed synthesis of a 3D non‐interpenetrated stp net COF, namely TUS‐64, with the largest pore size of all 3D COFs (47 Å) and record‐low density (0.106 g cm−3) by reticulating a 6‐connected triptycene‐based linker with a 4‐connected porphyrin‐based linker. Characterized with a highly interconnected mesoporous scaffold and good stability, TUS‐64 shows efficient drug loading and controlled release for five different drugs in simulated body fluid environment, demonstrating the competency of TUS‐64 as drug nanocarriers.

A ‘confined space’ provides a unique environment to regulate the crystallization thermodynamics and kinetics by confining the reactants in the restricted space dimensions. Solid-state crystal-to-crystal transitions in confined space are controlled by the preassembly of molecules in crystal lattice and occur inside the lattice. Herein we report the first case of construction of crystalline porous polyacetylene frameworks (PPFs) through solid-state cross-linking of acetylenic groups-bridged 2D crystalline covalent organic frameworks (COFs) in spatially limited systems. Specifically, this transformation is thermally induced yielding PPFs with superlative properties like outstanding enhancement in crystallinity, specific surface area and stability. We further demonstrate the PPFs as high conductivity polymers after iodine doping. This work underscores the opportunity in using lattice-constrained solid-state cross-linking to develop more versatile and feature-rich polyacetylene frameworks.